Patches, Needles, and Lollipops...

Size: px
Start display at page:

Download "Patches, Needles, and Lollipops..."

Transcription

1 Patches, Needles, and Lollipops... Jaime Lintemoot Los Angeles County Department of Coroner CAT - November Culver City

2 Objectives Fentanyl Routes of Administration Fentanyl Screening Methodologies 2 Year Fentanyl Study Results Conclusions

3 History of Fentanyl Synthesis Synthetic Opioid Belgium, Late 1950 s Janssen Pharmaceutica Use Clinical Use Surgical Anesthetic United States 1967 Schedule II Drug

4 Fentanyl Synthetic Narcotic Analgesic x more potent than Morphine Short Acting <30 Min Side Effects Severe Respiratory Depression Muscle Rigidity Seizures Hypotension Coma & Death Fentanyl C 22 H 28 N 2 O MW = Lethal Levels = 8-9 ng/ml *

5 The Needle Sublimaze Intravenous & Intramuscular Injection Anesthetic/Analgesic Dosage 50 ug/ml ampules ug administration Types of Abuse...

6 The Needle - Case Study #1 38-yo Male Unresponsive in Bathroom Hx of EtOH & Drug Abuse Fresh Trackmarks Syringe On Floor

7 The Needle - Case Study #1 Toxicology Results Fentanyl 10 ng/ml H. Blood Femoral 2.4 ng/ml EtOH 0.06 g% 0.06 g% Cause of Death Fentanyl Intoxication Mode of Death Accident

8 The Needle - Case Study #2 49-yo Female Nurse Anesthetist Unresponsive in Bed IV Left Arm Syringe Right Hand Recent Depression 1 Prior Suicide Attempt

9 The Needle - Case Study #2 Toxicology Results H. Blood Femoral Fentanyl 17 ng/ml 2.0 ng/ml Lidocaine 2.5 ug/ml 0.82 ug/ml Sertraline 0.31 ug/ml 0.18 ug/ml Norsertraline 1.7 ug/ml 0.35 ug/ml Morphine 0.87 ug/ml 0.22 ug/ml EtOH 0.14 g% 0.12 g% Laudanosine Present --- Medical Evidence Syringe Lidocaine Atracurium (Laudanosine) Cause /Mode of Death?

10 The Patch Duragesic Transdermal Delivery System Pain Management Dosage mg Patches ug/hr per 72 hrs Types of Abuse...

11 The Patch - Case Study #3 52-yo male Dr s Appointment 12/24/ hours Back Pain & Depression Fentanyl Patches Investigation 12/24/ hours Unresponsive Parking Lot of Dr s Office 2 of 10 Patches remaining

12 The Patch - Case Study #3 Toxicology Results H. Blood Femoral Fentanyl 115 ng/ml 36 ng/ml EtOH 0.09 g% 0.10 g% Clonazepam 21 ng/ml --- Hydrocodone 0.04 ug/ml --- Lorazepam 132 ng/ml --- Cause of Death Multiple Drug Intoxication Mode of Death Accident

13 Types of Abuse. Multiple Patches Intravenous Injection of Patch Material Application of Patch w/heat Previously Used Patches Frozen Patches - Chiclets??? Patch Abuse

14 The Lollipop Oralet Transmucosal Absorption Pre/Post Operative Dosage: ug minutes before procedure 5-15 ug/kg

15 The Lollipop Actiq Transmucosal Absorption Cancer Pain Dosage: ug Consume w/in 15 minutes 4 per day

16 The Lollipop - Case Study # 4 45-yo Male Unresponsive in Bathroom AIDS, Depression, Sinusitis & Severe Back Pain Bag w/ Lollipops in Adjacent Room

17 The Lollipop - Case Study #4 Medical Evidence 10 of 48 Lollipops Intact Toxicology Results Fentanyl Cocaine BE Hydrocodone Mirtazapine Cause of Death Coc/Fent/HC Use Mode of Death Accident H. Blood 1.7 ng/ml 0.33 ug/ml 0.50 ug/ml 0.03 ug/ml < 0.10 ug/ml

18 Illicit Fentanyl Use & Abuse Rx Drug Abuse Patches, Needles and Lollipops Hospital Administration Street Use & Manufacturing 10+ analogs Smoke, Snort & Inject The Toxicology Problem.

19 Fentanyl Screening Dr. s Request or Pharmaceutical Drug Screen Liquid/Liquid Extraction 3 ml Sample Size Deuterated Internal Standard Basic Shake Out with an Acid Back Extraction Evaporate & Reconstitute in MEOH GC/MS - SIM

20 Fentanyl Screening Problem L/L Extraction - Sensitivity - Inconsistencies ELISA Technology - 3 Months - All Toxicology Cases - Results???

21 Fentanyl Screening Case 40-yo Male Medical History of AIDS/HIV Unresponsive in Bed Transported to Hospital by Paramedics Unable to Revive Rx Meds: Epivir, Stauvudine, Atropine, Bactrim, Dilaudid, Pyrimethamine, Viramune, Catifluxalin, Paxil, Compazine, Hydroxyzine, Tagamet, Levofloxalin, Risperidal, Prevacid, and Ducusate

22 Fentanyl Screening Case Toxicology Results H. Blood Femoral Meperidine <0.10 ug/ml --- Normeperidine 0.13 ug/ml --- Norchlorcyclizine <0.10 ug/ml --- Paroxetine <0.10 ug/ml --- BE 0.19 ug/ml --- Hydromorphone ND 0.13 ug/ml Fentanyl 9.2 ng/ml 7.7 ng/ml Cause of Death Multiple Drug Intoxication Mode of Death Accident

23 Fentanyl Screening Revised Determination of Screening Procedures Practicality & Feasibility? The Study All Comprehensive Screens ( C ) 2 Years ELISA Technology for Screening L/L Extraction for Quantitation

24 Fentanyl Screening via ELISA Manual Set Up 100 ul Sample Negative Controls, & Positive Controls (1 2.5ng/ml) 900 ul Buffer Instrument Setup Tecan Minilyser Immunalysis FENTANYL Direct ELISA Kit

25 Fentanyl Screening via ELISA Automation 20 ul Sample into a 96- well plate 100 ul Conjugate Incubation 100 ul Color Reagent 100 ul Stop Solution Spectrophotometer

26 Fentanyl Screening Results December September 2003 Toxicology Cases = 9,402 C Screens = 3,495 ELISA (+) Fentanyl Cases = 170 Presumptive Positive Rate = 4.9% Confirmed Fentanyl Cases = 95 Confirmation Rate = 56% Fentanyl Positive Rate = 2.7%

27 (+) Fentanyl Statistics Modes of Death (95) 55 Accidents 3 Homicides 18 Naturals 8 Suicides 11 Und./Deferred Demographics Ages Average Age: 51 Years Gender 45 Male, 50 Female

28 (+) Fentanyl Statistics 95 Cases 20 Cases w/patches 2 Cases w/ Lollipops 4 Cases w/ Needles 3 Cases involving Nurses 49 Hospital Cases 23 Cases Undetermined Source

29 (+) Fentanyl Statistics 37 Cases (95): Cause of Death - Fentanyl Related H. Blood Ranges = ng/ml 26 Cases (95): Hospital Admin. Fentanyl - Not COD H. Blood Ranges = < ng/ml 47 Cases (95): Missed by Routine Screening Procedures 13 Cases (45): Cause of Death - Fentanyl Related H. Blood Ranges = < ng/ml, Ave = 7.7 ng/ml 49% of Fentanyl (+) Cases Missed by L/L Extraction 1.3% of All C Screens Missed by L/L Extraction

30 Conclusions Patches, Needles & Lollipops Sensitivity of Screening Procedures L/L Extraction ~ 7.7 ng/ml ELISA ~ 1.0 ng/ml 49% of (+) Fentanyl Cases Missed by L/L Extraction Confirmed Fentanyl Cases 2.7% of C Screens (+) for Fentanyl 35% of (+) Fentanyl Cases were Fentanyl Related COD

31 Where do we go from here? Laboratory Considerations... Fentanyl vs PCP Cost vs Relevance Other Approaches? Extended C Screens Looking into Case Histories New Abuse Problems? Illicit Fentanyl Detection?

32 Acknowledgements Los Angeles County Department of Coroner Forensic Toxicology Staff

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008

More information

Opioids - Fentanyl - Naloxone. Public Health Nurse

Opioids - Fentanyl - Naloxone. Public Health Nurse Opioids - Fentanyl - Naloxone Public Health Nurse What are Opioids? Opioids are a family of drugs that treat pain and can cause sleepiness. Prescription (legal) Opioids fall into 3 main categories: 1.

More information

Your Results are Our Priority.

Your Results are Our Priority. Your Results are Our Priority. Enzyme Linked Immunosorbent Assay (ELISA) One year shelf life Ready to use, color coded reagents and bottles Single dilution factor Adaptable for all forensic matrices Forensic

More information

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin

More information

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,

More information

Drug Screening: Things You Need to Know

Drug Screening: Things You Need to Know Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,

More information

BC Coroners Service Prescription Opiate-Related Overdose Deaths

BC Coroners Service Prescription Opiate-Related Overdose Deaths This report summarises prescription opiate-related overdose deaths reported to the BC Coroners Service between 2005 and 2010 with a classification of accidental, suicide, or undetermined. Cases were included

More information

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Mike Frontz, Robert Rodriguez, Gary Kunsman Bexar County Medical Examiner s Office, San Antonio, TX Brad Hall, Patricia Schroeder,

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

Deaths related to fentanyl misuse

Deaths related to fentanyl misuse NCIS Fact Sheet. October 2012 Deaths related to fentanyl misuse Deaths related to fentanyl misuse showed the following characteristics: ISSN 2201-2192 - most involved males - three-quarters were unintentional

More information

Duragesic patch. Duragesic patch (fentanyl patch) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 6 Last Review Date: March 18, 2016 Duragesic patch Description Duragesic patch (fentanyl

More information

Surveillance of Apparent Opioid Overdoses in New Brunswick

Surveillance of Apparent Opioid Overdoses in New Brunswick Surveillance of Apparent Opioid Overdoses in New Brunswick 7- Quarter 4 April, 8 Surveillance of apparent opioid overdoses in New Brunswick, 7 Q4 Page of Surveillance of Apparent Opioid Overdoses in New

More information

Conversion chart from fentanyl to opana er

Conversion chart from fentanyl to opana er Conversion chart from fentanyl to opana er (e.g., Nucynta). Both opioid products involved in conversion are one of the following: morphine, oxycodone, oxymorphone, hydromorphone (not extended- release),

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Ottawa Public Health Pam Oickle Sarah Archer

Ottawa Public Health Pam Oickle Sarah Archer Ottawa Public Health Pam Oickle Sarah Archer Pam Oickle Supervisor, Site Needle & Syringe Program Public Health Nurse 15 years Sarah Archer Public Health Nurse, Site Needle & Syringe Program 3 years Pamela.Oickle@Ottawa.ca

More information

4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t

4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless

More information

Opiate/opioid-Related Deaths in New Hampshire. Thomas A. Andrew, MD Chief Medical Examiner State of New Hampshire

Opiate/opioid-Related Deaths in New Hampshire. Thomas A. Andrew, MD Chief Medical Examiner State of New Hampshire Opiate/opioid-Related Deaths in New Hampshire Thomas A. Andrew, MD Chief Medical Examiner State of New Hampshire A National Public Health Issue Since 2000 drug deaths increased 137% 200% increase in opioids

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

Have A Nice Tryptamine. Brian Waters LA County Coroner CAT San Francisco June, 2006

Have A Nice Tryptamine. Brian Waters LA County Coroner CAT San Francisco June, 2006 Have A Nice Tryptamine Brian Waters LA County Coroner CAT San Francisco June, 2006 What s In A Tryptamine? Tryptamine (3-(2-aminoethyl)indole) Monoamine compound Widespread in nature Biosynthesis proceeds

More information

Drug and Opioid Epidemic Report

Drug and Opioid Epidemic Report Drug and Opioid Epidemic Report William Nettleton, MD, MPH Mary Franks, MPH For more information or questions about this report, contact hcsdata@kalcounty.com. 311 East Alcott St Kalamazoo, MI 49001 Phone:

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

disease or in clients who consume alcohol on a regular basis. bilirubin

disease or in clients who consume alcohol on a regular basis. bilirubin NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A

More information

Montgomery County Poisoning Death Review:

Montgomery County Poisoning Death Review: Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research 5-6-214 Montgomery County Poisoning Death Review: 21-213

More information

Ernest D. Stewart, Chief Published Deputy January Coroner/Public 2018 Administrator

Ernest D. Stewart, Chief Published Deputy January Coroner/Public 2018 Administrator 1 P a g e William F. Honsal, Sheriff Ernest D. Stewart, Chief Published Deputy January Coroner/Public 2018 Administrator METHODS Overview: The purpose of this report is to describe trends in the number

More information

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008 INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department

More information

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I chedule II Controlled ubstances: Basics and Beyond James L. Besier, Ph.D., R.Ph., FAHP Adjunct Associate Professor College of Nursing Adjunct Assistant Professor James L. Winkle College of Pharmacy University

More information

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

Oxymorphone (Opana ) is indicated for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate.

Oxymorphone (Opana ) is indicated for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate. Page 1 of 7 Policies Repository Policy Title Policy Number Schedule II Prior Authorization FS.CLIN.16 Application of Pharmacy Policy is determined by benefits and contracts. Benefits may vary based on

More information

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives Responding to the Opioid Crisis Responding to the Opioid Crisis David Cohen Ramsen Kasha Objectives Gain knowledge on Current opioid epidemic Historical perspective of opioids The impact of opioids on

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

Grand Rapids Police Department

Grand Rapids Police Department Heroin Heroin is an opioid drug made from morphine, a natural substance taken from the seed pod of the various opium poppy plants grown in Southeast and Southwest Asia, Mexico, and Columbia. Heroin can

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Expert Peer Review for Carfentanil

Expert Peer Review for Carfentanil Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential

More information

OPIOIDS. Testing and Interpretation

OPIOIDS. Testing and Interpretation OPIOIDS Testing and Interpretation TOPICS OF DISCUSSION Effects of Opioids Opiates vs. Opioids Drug Testing Recent Trends OPIOIDS: Testing and Interpretation 2018 2 EFFECTS OF OPIOIDS 3 Opioid Receptors

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

The Population is Abusing Drugs, but are Drugs Abusing Insurance? Image licensed from Shutterstock The Population is Abusing Drugs, but are Drugs Abusing Insurance? 01/30/2018 Gina C. Guzman, MD, DBIM, FALU, FLMI, VP and Chief Medical Director Tim Morant, FSA, MAAA,

More information

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview EXPANDED MAINE DRUG DEATH REPORT FOR 216 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine This report, funded by the Maine Office of Attorney General, provides a summary of

More information

Illicit Opioid and Methamphetamine Trends in Maine

Illicit Opioid and Methamphetamine Trends in Maine Illicit Opioid and Methamphetamine Trends in Maine Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine Objectives Provide an overview of the illicit opioid crisis in Maine, focusing

More information

Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia.

Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Created: Monday, March 12. Online calculator to convert equianalgesic

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Respiratory Depression

Respiratory Depression Respiratory Depression H. William Gottschalk, D.D.S. Fellow, Academy of General Dentistry Fellow, American Dental Society of Anesthesiology Diplomate, American Board of Dental Anesthesiology Diplomate,

More information

Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents,

Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents, Six Years of Opioid-Involved Accidental and Undetermined Fatalities among Connecticut Residents, 2009-2014 Lauretta E. Grau, Russell Skip Barbour, and Shawn M. Lang Background Heroin Deaths FDA efforts

More information

High-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP)

High-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP) High-Alert Medications: A Look at the Safe Use of Narcotics Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP) Risk Identification in Healthcare The detection of a potential or actual

More information

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms: Opioid Overdose Best Practices Guideline Table of Contents A. General description B. Typical signs and symptoms C. Expected course D. Making the diagnosis E. Recommended treatment F. Criteria for hospital

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

Opioids. Sergio Hernandez, MD

Opioids. Sergio Hernandez, MD Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

Validation of an Automated Method to Remove

Validation of an Automated Method to Remove Shahana Wahab Huq 1, Richard Thomas 2, Agnes Cua 2, Seyed Sadjadi 1 1 Phenomenex, 411 Madrid Avenue, Torrance, CA 951 2 Precision Toxicology, 33 Bunker Hill Street, San Diego, CA 9219 Validation of an

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

Revised 16 February, of 7

Revised 16 February, of 7 341 State Street Suite G Madison, WI 53703 ph: (608) 251 4454 f: (608) 251 3853 6333 University Avenue, Middleton WI 53562 ph: (608) 310 5389 f: (608) 285 9603 INTRANASAL OR INTRAMUSCULAR NALOXONE PROTOCOL:

More information

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

Drug Adherence Assessment Report

Drug Adherence Assessment Report Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

Demerol 50 mg vs hydrocodone

Demerol 50 mg vs hydrocodone Demerol 50 mg vs hydrocodone The Borg System is 100 % Demerol 50 mg vs hydrocodone 7-2-2016 What's the difference between the effects of Demerol and. Oxycodone 15-20 mg (orally) Vicodin (hydrocodone).

More information

~ CH2CH2. Duragesic Transdermal Patch: Postmortem Tissue Distribution of Fentanyl in 25 Cases. Abstract ~NCOCH2CH3. Introduction.

~ CH2CH2. Duragesic Transdermal Patch: Postmortem Tissue Distribution of Fentanyl in 25 Cases. Abstract ~NCOCH2CH3. Introduction. Duragesic Transdermal Patch: Postmortem Tissue Distribution of Fentanyl in 25 Cases Daniel T. Anderson* and Joseph J. Muto Los Angeles County Department of Coroner, 1104 North Mission Road, Los Angeles,

More information

OFFICE OF THE CORONER Annual Statistical Report. Mark J. Ward, Coroner th Street, Ste 325 Greeley, CO Website:

OFFICE OF THE CORONER Annual Statistical Report. Mark J. Ward, Coroner th Street, Ste 325 Greeley, CO Website: OFFICE OF THE CORONER 2014 Annual Statistical Report Mark J. Ward, Coroner 915 10th Street, Ste 325 Greeley, CO 80631 Website: www.co.weld.co.us Pub: March 2015 1 TABLE OF CONTENTS Forward Pg 3-7 Community

More information

A First Look at Duloxetine (Cymbalta in a Postmortem Laboratory

A First Look at Duloxetine (Cymbalta in a Postmortem Laboratory A First Look at Duloxetine (Cymbalta in a Postmortem Laboratory D. Anderson, S. Reed, J. Lintemoot, S. Kegler, S. DeQuintana, M. Sandberg, and J. Muto Los Angeles County Department of Coroner, 1104 N.

More information

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient? CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult

More information

PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL

PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL HARBOR-UCLA MEDICAL CENTER PEDIATRIC ANALGESIA AND SEDATION DRUG MANUAL SECTION Preface Disclaimer Nonpharmacologic Methods Table of Contents PAGE i ii iii

More information

DRUG OVERDOSE DEATHS ANALYSIS

DRUG OVERDOSE DEATHS ANALYSIS Overview CUYAHOGA COUNTY MEDICAL EXAMINER DRUG OVERDOSE DEATHS ANALYSIS Analysis of Fentanyl-Related Overdose Deaths in Cleveland/Cuyahoga County, Ohio in 2014 April 2015 The Cuyahoga County Medical Examiner

More information

Product Catalog. May We are Toxicology. Tel Toll Free Fax

Product Catalog. May We are Toxicology. Tel Toll Free Fax Product Catalog May 2014 www.immunalysis.com We are Toxicology. Tel 909.482.0840 Toll Free 888.664.8378 Fax 909.482.0850 Comprehensive Drug Testing Solutions 21 Urine HEIA Assays 37 ELISA Assays for Multiple

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem Objectives Discuss the recent spread of opioid misuse Discuss the rise of the current opioid crisis, a national addiction/overdose problem Includes medical and illicit opioids Objectives Discuss the dangers

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Long Term Care Formulary HCD - 08

Long Term Care Formulary HCD - 08 1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally

More information

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

2018 APM Winter Meeting San Antonio, TX

2018 APM Winter Meeting San Antonio, TX Moving target: The opioid crisis in the era of illicit fentanyl Alexander Y. Walley, MD, MSc Associate Professor of Medicine, BUSM Director, Addiction Medicine Fellowship, BMC Medical Director, Opioid

More information

Fundamentals of Pharmacology

Fundamentals of Pharmacology West Los Angeles College Worksheet #1 Fundamentals of Pharmacology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. By which of the following routes are

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia.

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia. LESSON ASSIGNMENT LESSON 11 Narcotic Agents. LESSON ASSIGNMENT Paragraphs 11-1--11-7 LESSON OBJECTIVES After completing this lesson, you should be able to: 11-1. Given a group of definitions, select the

More information

PAIN CONTROL IN THE PATIENT WITH ACUTE/CHRONIC PAIN JAY E. OLSSON,DO AOBPMR DCAQPM ABPMR ABPM

PAIN CONTROL IN THE PATIENT WITH ACUTE/CHRONIC PAIN JAY E. OLSSON,DO AOBPMR DCAQPM ABPMR ABPM PAIN CONTROL IN THE PATIENT WITH ACUTE/CHRONIC PAIN JAY E. OLSSON,DO AOBPMR DCAQPM ABPMR ABPM Disclaimers Speaker Bureau Avanir Pharmaceuticals Nuedexta Pfizer Inc. Embeda Lyrica FOCUS Pharmacologic interventions

More information

Fentanyl, Opioid Overdose and Naloxone

Fentanyl, Opioid Overdose and Naloxone Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians

More information

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics

More information

Prescription/OTC. Paola Caliguiran and Savanna Walker

Prescription/OTC. Paola Caliguiran and Savanna Walker Prescription/OTC Paola Caliguiran and Savanna Walker Facts Prescription drug abuse is when someone takes a medication that was prescribed for someone else or takes their own prescription in a way not intended

More information

EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine This report, funded by the Maine Office of Attorney General, provides a summary of

More information

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease)

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta Page: 1 of 7 Last Review Date: March 18, 2016 Nucynta Description Nucynta IR/ Nucynta

More information

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subsection: Analgesics and Opioids Original Policy Date: May 8, 2015 Subject: Meperidine Page: 1 of 5 Last

More information

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~ 2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients

More information

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D. Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva Edward J. Cone, Ph.D. Johns Hopkins School of Medicine, Baltimore, MD & ConeChem Research,

More information

A National Perspective on the Abuse and Diversion of Prescription Drugs

A National Perspective on the Abuse and Diversion of Prescription Drugs A National Perspective on the Abuse and Diversion of Prescription Drugs Hilary L. Surratt, Ph.D Steven P. Kurtz, Ph.D. ARSH: Center for Applied Research on Substance Use and Health Disparities Faculty

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing

One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing & One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing Speaker Frederick G. Strathmann Learning Objectives Discuss

More information

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do?: The term opioid can be

More information

The Opioid Epidemic: Overdose Data in NYC

The Opioid Epidemic: Overdose Data in NYC The Opioid Epidemic: Overdose Data in NYC Sindhu Shamasunder, MPH Bureau of Alcohol and Drug Use Prevention, Care and Treatment NYC Department of Health and Mental Hygiene The burden of drug overdose Nationally,

More information

Oxycontin conversion to ms contin

Oxycontin conversion to ms contin Oxycontin conversion to ms contin The Borg System is 100 % Oxycontin conversion to ms contin Ms contin to morphine conversion MS Contin is. The patient s current dose of 240 mg per day of oral oxycodone

More information

Analgesia is a labeled indication for all of the approved drugs I will be discussing.

Analgesia is a labeled indication for all of the approved drugs I will be discussing. Comparative Opioid Pharmacology Disclosure Analgesia is a labeled indication for all of the approved drugs I will be discussing. I ve consulted with Glaxo (remifentanil), Abbott (remifentanil), Janssen

More information

Morphine Sulfate Hydromorphone Oxymorphone

Morphine Sulfate Hydromorphone Oxymorphone Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.33 Subject: Morphine Drug Class Page: 1 of 8 Last Review Date: June 19, 2015 Morphine Sulfate Hydromorphone

More information

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, )

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, ) All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy (Paraclesus, 1493-1541) Discussion Questions About Paraclesus Quote 1. Do you agree

More information

Leveraging data to monitor the rise of cocaine and methamphetamine in Philadelphia

Leveraging data to monitor the rise of cocaine and methamphetamine in Philadelphia Leveraging data to monitor the rise of cocaine and methamphetamine in Philadelphia Lia N. Pizzicato, MPH Substance Use Epidemiologist Philadelphia Department of Public Health Learning Objectives 1 2 3

More information

Methods for Identifying Street & Prescription Drug Abuse

Methods for Identifying Street & Prescription Drug Abuse Methods for Identifying Street & Prescription Drug Abuse presented by Sharon S. Kelley, MS, PhD Chief Executive Officer Associates In Emergency Medical Education, Inc. Alliance for Global Narcotics Training,

More information